Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Many people
On WADA's 2026 Prohibited List, BPC-157 falls under S0 (Non-Approved Substances), while TB-500 falls under S2, the peptide hormones and growth factors section
Freeze rules: do not repeatedly freezethaw a reconstituted solution
Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity [3] , though human clinical data remain limited to early-phase safety trials and small case reports [4] [5]
The Baltimore Hospital is acknowledged as the first to develop vitamin cocktails that can be injected or administered intravenously
Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio
